Altimmune, Inc. (NASDAQ:ALT) Q1 2024 Earnings Conference Call May 9, 2024 8:30 AM ET

Company Participants

Rich Eisenstadt - Chief Financial Officer
Vipin Garg - President & Chief Executive Officer
Scott Harris - Chief Medical Officer
Scot Roberts - Chief Scientific Officer

Conference Call Participants

Roger Song - Jefferies
Alana Lelo - Guggenheim
Mayank Mamtani - B. Riley Securities
Jon Wolleben - Citizens JMP

Operator

Good day, ladies and gentlemen and welcome to Altimmune Inc. First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, this call is being recorded.

I would now like to introduce your host for today's conference, Rich Eisenstadt, Chief Financial Officer of Altimmune. Rich, you may begin.

Rich Eisenstadt

Thank you, Gigi and good morning, everyone. Thank you for participating in Altimmune’s first quarter 2024 financial results and business update conference call. Members of Altimmune team joining me on the call today are Vipin Garg, our Chief Executive Officer; Scott Harris, our Chief Scientific Officer -- Scot Roberts, our Chief Scientific Officer; and Scott Harris, our Chief Medical Officer.

Following the prepared remarks from Vipin, Scott, Harris and myself, we will hold a question-and-answer session. A press release with our first quarter 2024 financial results was issued this morning and can be found on the Investor Relations section of the company's website.

Before we begin, I'd like to remind everyone that remarks about future expectations, plans and prospects constitute forward-looking statements for purposes of Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Altimmune cautions that these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those indicated.

For a discussion of some of the risks and factors that could affect the company's future results and operations, please see the risk factors and other cautionary statements contained in the company's filings with the SEC. I will also direct you to read the forward-looking statement disclaimer in our press release issued this morning and now available on our website.

Any statements made on this conference call speak only as of today's date, Thursday, May 9, 2024 and the company does not undertake any obligation to update any of these forward-looking statements to reflect events or circumstances that occur on or after today's date.